Login

Effective Royalty Rates In Biopharma Alliances: What They Are &, Why Use Them In Negotiations

By Mark G. Edwards

As a licensing professional in the biopharma industry for the past three decades, I’d argue that there is no component of a biopharma contract that is more heavily relied upon, and less rigorously analyzed, than the royalty rate.

Latest

Search LESI

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors